Kimberly-Clark (KMB) Seems Undervalued -Barron's
Tweet
Share
E-mailGet Alerts KMB Hot Sheet
Price: $109.55 -0.39%
Rating Summary:
9 Buy, 15 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
9 Buy, 15 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Barron's published an article in this weekend's edition highlighting reasons why Kimberly-Clark (NYSE: KMB) stock looks compelling.
Valued at 14x the Street's FY08 EPS estimate of $4.54, shares of Kimberly-Clark are trading at about a 20% discount to its historical average and peer group average multiples. Additionally, Barron's also likes Kimberly-Clark's 3.7% dividend yield, which the Company has increased by 9.4% this year.
Barron's believes Kimberly-Clark will soon begin to benefit from a recent 4-7% price hike on some of its products. Considering the Company's already decent cash position of about $2.4 billion, Kimberly-Clark should be able to continue growing its dividend and buying back stock.
Barron's points out that Kimberly-Clark's CEO, Tom Falk, reaffirmed, in February, the Company's previously issued FY08 EPS guidance of $4.45-$4.60.
Kimberly-Clark is scheduled to report earnings tomorrow, April 22.
Kimberly-Clark Corporation engages in the manufacture and marketing of health and hygiene products worldwide. [BCS]
Valued at 14x the Street's FY08 EPS estimate of $4.54, shares of Kimberly-Clark are trading at about a 20% discount to its historical average and peer group average multiples. Additionally, Barron's also likes Kimberly-Clark's 3.7% dividend yield, which the Company has increased by 9.4% this year.
Barron's believes Kimberly-Clark will soon begin to benefit from a recent 4-7% price hike on some of its products. Considering the Company's already decent cash position of about $2.4 billion, Kimberly-Clark should be able to continue growing its dividend and buying back stock.
Barron's points out that Kimberly-Clark's CEO, Tom Falk, reaffirmed, in February, the Company's previously issued FY08 EPS guidance of $4.45-$4.60.
Kimberly-Clark is scheduled to report earnings tomorrow, April 22.
Kimberly-Clark Corporation engages in the manufacture and marketing of health and hygiene products worldwide. [BCS]
You May Also Be Interested In
- Freedom Broker Downgrades Workday (WDAY) to Hold
- Elastic NV. (ESTC) PT Raised to $130 at Piper Sandler
- Best Buy (BBY) PT Raised to $95 at DA Davidson Following Earnings
Create E-mail Alert Related Categories
Analyst Comments, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
